title: [Cytostatic and hormonal therapy on oncologic gynecology (author's transl)].
abstract: Horones as a therapeutic agent are practically not used in gynecologic oncology, because gynecological malignomas are hormonally independent. Therapeutically succesful in only the use of Progesterone in metastases and relapses of endometrial cancer and of Estrogen in the palliative treatment of cervical cancer relapses. However, significant results are obtained by cytostatic therapy, particularly in carcinomas of the ovary and in choriocarcinomas; the therapy is somewhat less successful in the cancer of the oviduct and vulva, while in the cancer of the cervix and vagina it is not successful at all. Polychemotherapy is recommended because it results in better remissions and is less aggressive.
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D011374:Progesterone / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D004967:Estrogens; D011374:Progesterone
vernacular_title: Hormonska in citostatska terapija v onkoloski ginekologiji.